Legal & General Group’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $771K | Buy |
62,620
+9,155
| +17% | +$113K | ﹤0.01% | 2315 |
|
|
2025
Q1 | $329K | Buy |
53,465
+46,861
| +710% | +$288K | ﹤0.01% | 2522 |
|
|
2024
Q4 | $53.5K | Buy |
6,604
+536
| +9% | +$4.34K | ﹤0.01% | 2768 |
|
|
2024
Q3 | $49K | Sell |
6,068
-83
| -1% | -$671 | ﹤0.01% | 2795 |
|
|
2024
Q2 | $26.6K | Buy |
6,151
+231
| +4% | +$1K | ﹤0.01% | 2912 |
|
|
2024
Q1 | $25.1K | Sell |
5,920
-256
| -4% | -$1.09K | ﹤0.01% | 2887 |
|
|
2023
Q4 | $23.2K | Buy |
6,176
+606
| +11% | +$2.28K | ﹤0.01% | 2976 |
|
|
2023
Q3 | $20.6K | Buy |
5,570
+252
| +5% | +$932 | ﹤0.01% | 3017 |
|
|
2023
Q2 | $21.1K | Buy |
+5,318
| New | +$21.1K | ﹤0.01% | 3096 |
|
|
2022
Q2 | – | Sell |
-3,200
| Closed | -$18K | – | 3552 |
|
|
2022
Q1 | $18K | Hold |
3,200
| – | – | ﹤0.01% | 3263 |
|
|
2021
Q4 | $15K | Hold |
3,200
| – | – | ﹤0.01% | 3361 |
|
|
2021
Q3 | $15K | Sell |
3,200
-236
| -7% | -$1.11K | ﹤0.01% | 3359 |
|
|
2021
Q2 | $24K | Sell |
3,436
-284
| -8% | -$1.98K | ﹤0.01% | 3225 |
|
|
2021
Q1 | $37K | Hold |
3,720
| – | – | ﹤0.01% | 2919 |
|
|
2020
Q4 | $28K | Hold |
3,720
| – | – | ﹤0.01% | 2964 |
|
|
2020
Q3 | $22K | Sell |
3,720
-247
| -6% | -$1.46K | ﹤0.01% | 2942 |
|
|
2020
Q2 | $25K | Hold |
3,967
| – | – | ﹤0.01% | 2966 |
|
|
2020
Q1 | $14K | Sell |
3,967
-855
| -18% | -$3.02K | ﹤0.01% | 3047 |
|
|
2019
Q4 | $33K | Buy |
4,822
+887
| +23% | +$6.07K | ﹤0.01% | 3001 |
|
|
2019
Q3 | $25K | Hold |
3,935
| – | – | ﹤0.01% | 3054 |
|
|
2019
Q2 | $30K | Buy |
+3,935
| New | +$30K | ﹤0.01% | 3015 |
|